Explore ALPCO's Diverse Products for Gastroenterology Research
ALPCO offers targeted GI solutions suitable for all types of labs. Our offerings range from plate-based to clinical chemistry analyzer-based and automated flash chemiluminescence solutions, all designed to accommodate your lab’s expanding testing needs and capabilities. ALPCO specialists leverage their expertise to curate a growing collection of resources for your gastroenterology research and testing, including the most up-to-date product information, AGA guideline infographics, white papers, and on-demand webinars.
Live Webinar: A Clinical Laboratory’s Perspective on Fecal Calprotectin Testing
Join our speaker from ARUP Laboratories, Dr. Heather Nelson, for a discussion on Automated Fecal Calprotectin Testing. As more clinicians adopt AGA guidelines related to treatment monitoring in Crohn’s Disease and Ulcerative Colitis, Calprotectin testing rates continue to increase.
This inspiring webinar, “A Clinical Laboratory’s Perspective on Fecal Calprotectin Testing” offers helpful in-house automated insights into:
Selection ; Implementation; Cost/Workflow Advantages
Date: Tuesday, November 19th
Time: 12pm EST
[Infographic] Biomarker Monitoring for the Management of Crohn’s Disease
Download ALPCO's infograhpic and gain an overview of the American Gastroenterological Association (AGA) guidelines, offering a new perspective on managing Crohn's Disease using biomarkers.
[Poster]Evaluation and method comparison of a rapid automated fecal calprotectin assay in patients suspected of having inflammatory bowel disease
Download poster to discover how the ALPCO Fecal Calprotectin Assay enables faster, non-invasive IBD and IBS diagnosis and compares leading calprotectin tests.
Accuracy in Calprotectin Testing
ALPCO's automated calprotectin test improves efficiency while maintaining sensitivity and specificity, allowing clinicians to prioritize endoscopies and treat IBS patients.
Webinar On-Demand: Optimizing IBD Management with Fecal Calprotectin - From Diagnosis to Monitoring
In the webinar, Dr. Benjamin Click from the University of Colorado, Department of Gastroenterology, underscores the critical role of non-invasive monitoring methods, particularly fecal calprotectin monitoring, in guiding treatment adjustments and achieving therapeutic goals..
Spotlight: Immunoturbidimetric Assay for Fecal Calprotectin
Extraction to Results – Simplify Complexity
Leverage the power of our FDA-Cleared Immunoturbidimetric (IT) Assay for fecal calprotectin designed to integrate seamlessly with your existing clinical chemistry analyzer. Experience a method that is not only time and cost-efficient but also a viable alternative to conventional and send-out methodologies.
GET YOUR TIME BACK
Upgrading to ALPCO’s Immunoturbidimetric solution for calprotectin testing offers a 40%-65% reduction in time to first result compared to leading Flash Chemiluminescence automated systems.
ACCURACY
ALPCO’s Calprotectin IT Assay combines the clinical sensitivity and specificity clinicians expect with the efficiency and repeatability today’s laboratories require.
MAXIMIZE THROUGHPUT
Increase throughput by more than 57% when comparing tests per hour from a leading CLIA system to ALPCO’s Immunoturbidimetric assay running on a clinical chemistry analyzer.
COST SAVINGS
Realize a savings of up to 87% on the cost per test when comparing the average send-out cost to ALPCO’s in-house cost per test.
Ready to Schedule Your Free Evaluation?
See for yourself why labs are switching to ALPCO’s new FDA-cleared Calprotectin Immunoturbidimetric Assay.
One free kit per laboratory. Void where prohibited.
FAQs
The calprotectin immunoturbidimetric assay (80-CALPHU-IT200, -100) is 510(k)-cleared in the U.S., IVDD in the EU, and has been submitted for review by Health Canada.
It is recommended to run calibrators once per month and with every kit lot change. Two controls are typically run each day calprotectin testing is performed.
Unlike traditional ELISA, which could have up to 22 non-reportables per run (8 calibrators and 3 controls in duplicate), the immunoturbidimetric assay requires only two non-reportables (2 controls) per day, easily accommodating low volume to high volume testing at a competitive cost per test.
Follow ALPCO on Social Media
Stay up to date with new products, articles, and events.